Skip to main content
SpringerLink
Log in

Short-term lithium administration to healthy volunteers produces long-lasting pronounced changes in platelet serotonin uptake but not imipramine binding

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Platelet [3H]-5HT uptake, [3H]-imipramine binding and endogenous 5HT levels were measured in healthy volunteers during short-term (20 days) administration of lithium, and following its withdrawal. The V max of [3H]-5HT uptake was significantly decreased during lithium treatment. Following lithium withdrawal, platelet [3H]-5HT uptake (V max) remained decreased and was followed by a pronounced rebound effect in some of the subjects for up to 3 months. The affinity constant (K m) of [3H-5HT uptake was not modified. Binding of tritiated imipramine during the same period and platelet 5HT levels measured till 14 days after withdrawal was not affected by lithium treatment. As lithium is devoid of in vitro effects on both 5HT uptake and imipramine binding, it is concluded that the effects of lithium on the 5HT transporter do not reflect a direct effect on the transporter complex. Our results indicate that lithium-induced changes at the level of 5HT uptake in platelets are not correlated with concomitant variations in platelet 5HT content and can be dissociated from modifications at the level of imipramine binding sites within the macromolecular complex of the 5HT transporter. Moreover, platelet 5HT uptake is apparently modulated by lithium, with a similar pattern in healthy volunteers and in manic-depressive patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abraham KI, Ieni JR, Meyerson LR (1987) Purification and properties of a human plasma endogenous modulator for the platelet tricyclic binding/serotonin transport complex. Biochim Biophys Acta 923:8–21

    Google Scholar 

  • Ahtee L, Briley M, Raisman R, Lebrec D, Langer SZ (1981) Reduced uptake of serotonin but unchanged 3H-imipramine binding in the platelets from cirrhotic patients. Life Sci 29:2323–2329

    Google Scholar 

  • Alexander DR, Deeb M, Bitar F, Antun F (1986) Sodium-potassium, magnesium, and calcium ATPase activities in erythrocyte membranes from manic-depressive patients responding to lithium. Biol Psychiatry 21:997–1007

    Google Scholar 

  • Asarch KB, Shih JC, Kulcsar A (1980) Decreased 3H-imipramine binding in depressed males and females. Commun Psychopharmacol 4:425–432

    Google Scholar 

  • Baron M, Barkai A, Gruen R, Peselow E, Fieve RR, Quitkin F (1986) Platelet [3H]imipramine binding in affective disorders: trait versus state characteristics. Am J Psychiatry 143:711–716

    Google Scholar 

  • Born GVR, Grignani G, Martin K (1980) Long-term effect of lithium on the uptake of 5-hydroxytryptamine by human platelets. Br J Clin Pharmacol 9:321–325

    Google Scholar 

  • Braddock LE, Cowen PJ, Eliott JM, Fraser S, Stump K (1984) Changes in the binding to platelets of [3H]imipramine and [3H]yohimbine in normal subjects taking amitriptyline. Neuropharmacology 23:285–286

    Google Scholar 

  • Briley MS, Langer SZ, Raisman R, Sechter D, Zarifian E (1980) Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science 209:303–305

    Google Scholar 

  • Coppen A, Swade C, Wood K (1980) Lithium restores abnormal platelets 5-HT transport in patients with affective disorders. Br J Psychiatry 136:235–238

    Google Scholar 

  • Daniel WW (1978) Applied non-parametric statistics. Houghton Mifflin Company, Boston

    Google Scholar 

  • Habert E, Graham D, Tahraoui L, Claustre Y, Langer SZ (1985) Characterization of [3H]paroxetine binding to rat cortical membranes. Eur J Pharmacol 118:107–114

    Google Scholar 

  • Iwata H, Okamoto H (1973) Effect of lithium on the blood and intestinal serotonin contents of rats. Experientia 29:988–989

    Google Scholar 

  • Kamal LA, Cloix JF, Devynck MA, Meyer P (1983) [3H]Serotonin uptake in human blood platelets is reduced by ouabain and endogenous digitalis-like inhibitors of sodium, potassium ATPase. Eur J Pharmacol 92:167–168

    Google Scholar 

  • Kamal L, Raisman R, Meyer P, Langer SZ (1984) Reduced V max of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects. Life Sci 34:2083–2088

    Google Scholar 

  • Langer SZ, Briley MS, Raisman R, Henry JF, Morselli PL (1980a) Specific 3H-imipramine binding in human platelets: influence of age and sex. Naunyn-Schmiedeberg's Arch Pharmacol 313:189–194

    Google Scholar 

  • Langer SZ, Moret C, Raisman R, Dubocovich ML, Briley MS (1980b) High affinity 3H-imipramine binding in the rat hypothalamus is associated with the uptake of serotonin but not norepinephrine. Science 210:1133–1135

    Google Scholar 

  • Langer SZ, Lee CR, Segonzac A, Tateishi T, Schoemaker H, Winblad B (1984a) Possible endocrine role of the pineal gland for 6-methoxy-tetrahydrobetacarboline, a putative endogenous neuromodulator of the 3H-imipramine recognition site. Eur J Pharmacol 102:379–380

    Google Scholar 

  • Langer SZ, Raisman R, Tahraoui L, Scatton B, Niddam R, Lee CR, Claustre Y (1984b) Substituted tetrahydro-β-carbolines are possible candidates as endogenous ligand of the 3H-imipramine recognition site. Eur J Pharmacol 98:153–154

    Google Scholar 

  • Langer SZ, Sechter D, Loo H, Raisman R, Zarifian E (1986) Electroconvulsive shock therapy and maximum binding of platelet tritiated imipramine binding in depression. Arch Gen Psychiatry 43:949–952

    Google Scholar 

  • Le Quan-Bui KH, Plaisant O, Leboyer M, Gay C, Kamal L, Devynck MA, Meyer P (1984) Reduced platelet serotonin in depression. Psychiatr Res 13:129–139

    Google Scholar 

  • Meltzer HY, Arora RC, Goodnick P (1983) Effect of lithium carbonate on serotonin uptake in blood platelets of patients with affective disorders. J Affective Disord 5:215–221

    Google Scholar 

  • Nyström C, Ross SB, Hällström T, Kelder D (1986) Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Acta Psychiatr Scand 73:133–138

    Google Scholar 

  • Poirier MF, Benkelfat C, Loo H, Sechter D, Zarifian E, Galzin AM, Langer SZ (1986) Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors. Psychopharmacology 89:456–461

    Google Scholar 

  • Poirier MF, Le Quan-Bui KH, Loo H, Meyer P (1985) Changes in human platelet 5HT level after one week of chlorimipramine treatment. Psychopharmacology 86:194–196

    Google Scholar 

  • Poirier MF, Loo H, Benkelfat C, Sechter D, Zarifian E, Galzin AM, Schoemaker H, Segonzac A, Langer SZ (1984) [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment. Eur J Pharmacol 106:629–633

    Google Scholar 

  • Raisman R, Briley M, Langer SZ (1979) High-affinity 3H-imipramine binding in rat cerebral cortex. Eur J Pharmacol 54:307–308

    Google Scholar 

  • Raisman R, Briley M, Langer SZ (1980) Specific tricyclic antidepressant binding sites in rat brain characterized by high-affinity 3H-imipramine binding. Eur J Pharmacol 61:373–380

    Google Scholar 

  • Raisman R, Sechter D, Briley MS, Zarifian E, Langer SZ (1981) High affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers. Psychopharmacology 75:368–371

    Google Scholar 

  • Raisman R, Briley MS, Bouchami F, Sechter D, Zarifian E, Langer SZ (1982) 3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers. Psychopharmacology 77:332–335

    Google Scholar 

  • Ross SB, Äberg-Wistedt A (1983) Inhibitors of serotonin and noradrenaline noradrenaline uptake in human plasma after withdrawal of zimelidine and chlorimipramine treatment. Psychopharmacology 79:298–303

    Google Scholar 

  • Ross SB, Aperia B, Beck-Friis J, Jansa S, Wetterberg L, Äberg A (1980) Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo. Psychopharmacology 67:1–7

    Google Scholar 

  • Segonzac A, Raisman R, Tateishi T, Schoemaker H, Hicks PE, Langer SZ (1985) Tryptamine, a substrate for the serotonin transporter in human platelets modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction. J Neurochem 44:349–355

    Google Scholar 

  • Sneddon JM (1969) Sodium-dependent accumulation of 5-hydroxytryptamine by rat blood platelets. Br J Pharmacol 37:680–688

    Google Scholar 

  • Suranyi-Cadotte BE, Gauthier S, Lafaille F, Deflores S, Dam TV, Nair NPV, Quirion R (1985a) Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementia. Life Sci 37:2305–2311

    Google Scholar 

  • Suranyi-Cadotte BE, Lafaille F, Schwartz G, Nair NPV, Quirion R (1985b) Unchanged platelet 3H-imipramine binding in normal subjects after imipramine administration. Biol Psychiatry 20:1237–1240

    Google Scholar 

  • Suranyi-Cadotte BE, Quirion R, Nair NPV, Lafaille F, Schwartz G (1985c) Imipramine treatment differentially affects 3H-imipramine binding and serotonin uptake in depressed patients. Life Sci 36:795–799

    Google Scholar 

  • Weizman A, Carmi M, Hermesh H, Shahar A, Apter A, Tyano S, Rehavi M (1986a) High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients. Am J Psychiatry 143:335–339

    Google Scholar 

  • Weizman R, Carmi M, Tyano S, Apter A, Rehavi M (1986b) Reduced 3H-imipramine binding but unaltered 3H-serotonin uptake in platelets of adolescent enuretics. Life Sci 19:37–42

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hôpital Sainte-Anne, 1, rue Cabanis, F-75014, Paris, France

    M. F. Poirier, C. Gay & H. Loo

  2. Department of Biology, Laboratories d'Etudes et de Recherches Synthélabo (L.E.R.S.), 58, rue de la Glacière, F-75013, Paris, France

    A. M. Galzin, C. Pimoule, H. Schoemaker & S. Z. Langer

  3. Department of Pharmacology, INSERM U7, Hôpital Necker, 161, rue de Sevres, F-75015, Paris, France

    K. H. Le Quan Bui & P. Meyer

Authors
  1. M. F. Poirier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. M. Galzin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Pimoule
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Schoemaker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. H. Le Quan Bui
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Gay
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. Loo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S. Z. Langer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poirier, M.F., Galzin, A.M., Pimoule, C. et al. Short-term lithium administration to healthy volunteers produces long-lasting pronounced changes in platelet serotonin uptake but not imipramine binding. Psychopharmacology 94, 521–526 (1988). https://doi.org/10.1007/BF00212848

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00212848

Key words

Search

Navigation